We are live on
!
Find out more
AP
Arlington Partners Portfolio holdings
AUM
$55.4M
1-Year Est. Return
8%
This Fund
S&P 500
This Quarter
Est. Return
-1.22%
1 Year Est. Return
+8%
3 Year Est. Return
+43.69%
5 Year Est. Return
+33.63%
10 Year Est. Return
–
AUM
$258M
AUM Growth
+$1.93M
(+0.76%)
Cap. Flow
+$8.93M
Cap. Flow
% of AUM
3.47%
Top 10 Holdings %
Top 10 Hldgs %
33.45%
Holding
59
New
1
Increased
26
Reduced
25
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
+$30M |
| 2 |
Microsoft
MSFT
|
+$548K |
| 3 |
Equifax
EFX
|
+$541K |
| 4 |
Roper Technologies
ROP
|
+$532K |
| 5 |
Procter & Gamble
PG
|
+$441K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$3.72M |
| 2 |
Diageo
DEO
|
+$3.53M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.97M |
| 4 |
Becton Dickinson
BDX
|
+$2.86M |
| 5 |
Nike
NKE
|
+$2.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.13% |
| 2 | Technology | 14.93% |
| 3 | Industrials | 13.05% |
| 4 | Communication Services | 11.89% |
| 5 | Consumer Staples | 10.39% |
Similar funds
BWA
JRCM
EI
DCI
AA
CAM
MML
YAVAPFMC
Arlington Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Arlington Partners held 59 positions worth $258M, up 0.76% from $256M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Arlington Partners deployed $8.93M of net new capital in Q4 2024, opening 1 new position and adding to 26 existing holdings. Its largest new stake was Alphabet (Google) Class C: 2,307 shares worth $439K.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Diageo, an estimated $3.53M trimmed.
- Arlington Partners's largest Q4 2024 buy was Alphabet (Google) Class C: 2,307 shares worth $439K.
- Arlington Partners added most to Vanguard Dividend Appreciation ETF in Q4 2024, an estimated $30M increase.
- Arlington Partners's biggest Q4 2024 reduction was Diageo, cutting an estimated $3.53M.
- Arlington Partners fully exited Biogen in Q4 2024, selling an estimated $3.72M.
- Arlington Partners's ten largest holdings make up 33% of its $258M portfolio in Q4 2024.
- Arlington Partners opened 1 new position and closed 1 in Q4 2024.
- Arlington Partners's portfolio value rose 0.76% quarter-over-quarter to $258M.
Based on Arlington Partners's 13F filing for Q4 2024, filed 29 Jan 2025.